• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Introduction to 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline (CAS No. 1058062-64-8)

2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline, identified by its CAS number 1058062-64-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound belongs to the class of boron-containing heterocycles, which are widely recognized for their versatile applications in drug development and advanced material synthesis. The presence of both a tetramethyl-substituted dioxaborolane moiety and a trifluoromethyl aniline group imparts unique chemical properties, making it a valuable intermediate in synthetic chemistry and a potential candidate for innovative therapeutic applications.

The tetramethyl-1,3,2-dioxaborolan-2-yl group in the molecular structure is particularly noteworthy due to its stability and reactivity in cross-coupling reactions. This feature has been extensively utilized in modern synthetic methodologies, such as Suzuki-Miyaura coupling, which enables the formation of carbon-carbon bonds with high precision. Such reactions are fundamental in constructing complex molecular architectures, a critical aspect in the design of novel pharmaceuticals. The stability of the boronate ester under various reaction conditions makes it an ideal choice for facilitating these transformations without unwanted side products.

Concurrently, the trifluoromethyl group attached to the aniline ring introduces electron-withdrawing properties, which can modulate the electronic characteristics of the molecule. This modification is particularly relevant in medicinal chemistry, where trifluoromethyl groups are often incorporated into drug candidates to enhance metabolic stability, improve binding affinity to biological targets, and increase bioavailability. The combination of these two functional groups in 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline suggests a compound with broad utility in both synthetic chemistry and drug discovery.

Recent advancements in computational chemistry have further highlighted the potential of this compound. Molecular modeling studies indicate that the interaction between the boronate ester and transition metals can be finely tuned to optimize catalytic activity. This insight has opened new avenues for developing more efficient catalysts for cross-coupling reactions, which are pivotal in industrial-scale pharmaceutical synthesis. Moreover, the aniline moiety's ability to participate in hydrogen bonding interactions has been explored as a means to enhance molecular recognition processes, such as those involved in enzyme inhibition.

In the realm of pharmaceutical research, 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline has been investigated as a precursor for various biologically active molecules. For instance, its incorporation into heterocyclic scaffolds has led to compounds with promising antiviral and anti-inflammatory properties. The trifluoromethyl group's influence on pharmacokinetic profiles has been particularly studied, demonstrating its role in prolonging drug efficacy and reducing degradation rates. Such findings underscore the importance of this compound as a building block for next-generation therapeutics.

The compound's unique structural features also make it attractive for applications beyond pharmaceuticals. In materials science, for example, derivatives of 2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)aniline have been explored for their potential use in organic electronics and liquid crystal displays (LCDs). The electron-withdrawing nature of the trifluoromethyl group can influence charge transport properties, making it suitable for designing advanced functional materials. Additionally, the boronate ester functionality provides a handle for further chemical modifications via cross-coupling reactions, allowing for tailored material properties.

From a synthetic perspective, the preparation of 1058062-64-8 involves multi-step organic transformations that showcase modern synthetic techniques. The introduction of the tetramethyl-dioxaborolane group typically requires careful control over reaction conditions to ensure high yield and purity. Recent methodologies have focused on greener approaches to boronate ester synthesis, utilizing renewable solvents and catalysts to minimize environmental impact. These advancements align with global efforts to promote sustainable chemistry practices.

The role of computational tools in optimizing synthetic routes cannot be overstated. By leveraging machine learning algorithms and molecular dynamics simulations, researchers have been able to predict optimal reaction conditions and predict product outcomes with greater accuracy. This has significantly reduced experimental trial-and-error processes and accelerated the development pipeline for novel compounds like 1058062-64-8.

Future research directions may explore novel derivatives of this compound with enhanced functionalities or improved bioavailability profiles. The integration of biocatalysis into synthetic routes could also offer new possibilities for producing complex molecules more efficiently while maintaining high enantioselectivity—a critical factor in pharmaceutical development.

In conclusion, 1058062-64-8, or (tetramethyl-dioxaborolanyl)-4-trifluoroaniline, represents a fascinating compound at the intersection of synthetic chemistry and medicinal science. Its unique structural attributes provide opportunities for innovation across multiple disciplines—from developing next-generation drugs to designing advanced materials with tailored electronic properties.

• 214360-65-3(4,4,5,5-Tetramethyl-2-(4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane)
• 1126479-89-7(4,4,5,5-tetramethyl-2-3-methyl-4-(trifluoromethyl)phenyl-1,3,2-dioxaborolane)
• 1256358-84-5(4,4,5,5-Tetramethyl-2-(3-methyl-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane)
• 1234319-14-2(2-[4-(difluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
• 1196972-92-5(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)aniline)
• 325142-82-3(3-(Trifluoromethyl)phenylboronic Acid Pinacol Ester)
• 69807-91-6(2-(3,5-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)
• 510771-54-7(3-Amino-5-trifluoromethylphenylboronic acid, pinacol ester)
• 1259285-61-4(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)benzenamine)
• 627525-89-7(2-3-(difluoromethyl)phenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)